Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

225.60 -9.15 (-3.90%)
Official Closing Price Updated: 7:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
From Bio-Rad Laboratories, Inc.
Via Business Wire
Why Are velo Biosciences Stock Is Trading Higher Today?
Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO). 
Via Benzinga
Bio-Rad Announces New Share Repurchase Program
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
The Latest Analyst Ratings for Bio-Rad Laboratories
Via Benzinga
Death Cross Looms Over Bio-Rad Laboratories Investors
Via Benzinga
Recap: Bio-Rad Laboratories Q1 Earnings
Via Benzinga
Bio-Rad Publishes Corporate Sustainability Report for 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Golden Cross Appears Before Bio-Rad Laboratories Investors
Via Benzinga
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Earnings Outlook For Bio-Rad Laboratories
Via Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Stocks Roar Back To Life; Still Pacing For Weekly Loss
Rebounding bank stocks, stellar Apple earnings, and a blowout jobs report are all helping stocks move significantly higher Friday afternoon. 
Via Talk Markets
Bio-Rad Reports First-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
The 3 Most Promising Biotech Stocks to Buy Now
With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now. 
Via InvestorPlace
I Asked ChatGPT for 10 EV Stocks to Buy. Here’s What It Recommended.
What are the best EV stocks to buy? ChatGPT has different answers, depending on how it is asked. Here's what investors need to know. 
Via InvestorPlace
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems 
From Cytek Biosciences, Inc.
Via GlobeNewswire
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
Thoughts For Thursday: All Eyes On The CPI
All eyes are on the release of the December Consumer Price Index data later today. 2023 has started as a relatively up year for equities and a continued downward trajectory seems necessary to keep the... 
Via Talk Markets
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says
Via Benzinga
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.